Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection

Mise à jour : Il y a 4 ans
Référence : NCT00059462

Femme et Homme

Extrait

The purpose of this study is to evaluate the safety of the experimental drug Bay 50-4798 in HIV positive patients receiving HAART and to test the drug's effect on the CD4+ T-cell count.


Critère d'inclusion

  • HIV Infections

Liens